News In August 2019, Russia registered the drug nuzinersen ("Spinraza"), which is able to stop the progression of spinal muscular atrophy (SMA), and in some cases, improve the condition of people with this disease. Before that, there was no registered drug for the treatment of SMA in the Russian Federation. |